Skip to main content
Premium Trial:

Request an Annual Quote

Rat Genome, Tripos, Accelrys, Clinomics Biosciences, Spotfire, Inpharmatica, Geospiza


Bioinformatics Groups Tackle Rat Genome

The publication of the genome sequence of the brown Norway laboratory rat in Nature last week was accompanied by a barrage of bioinformatics data analyses in a special issue of Genome Research ( The April issue of the journal contains 30 papers describing in-depth analyses of the draft sequence, as well as several methods papers, including a description of the Atlas algorithm used to assemble the genome.

The genome was assembled at Baylor College of Medicine, and subsequent analysis was performed by over 20 groups in six countries using gene and protein predictions from the Ensembl project.

Tripos Releases Q4 ‘03 Earnings, Restates Prior Results

Tripos last week reported its financial results for the fourth quarter and full year ended Dec. 31, 2003, along with its restated financial results for prior years.

For the full year of 2003, Tripos posted revenues of $54.1 million, a 10 percent increase from the previous year’s revenues of $49.1 million. Revenues for the fourth quarter were down, however, to $12.6 million compared to $14.7 million in the fourth quarter of 2002.

Net income for 2003 was $2.1 million, and the company posted a $500,000 net loss for the quarter.

Tripos spent $2.7 million on R&D in the fourth quarter of 2003, up slightly from $ 2.6 million a year ago.

The company had $2.9 million in cash and cash equivalents as of Dec. 31, 2003.

Accelrys to Resell IBM Tools Via Avnet

Accelrys last week said that it would work with IT distributor Avnet Hall-Mark to resell IBM hardware solutions through Avnet’s Enablement Services Partnership program.

The agreement builds upon an existing partnership between IBM and Accelrys, and will allow Accelrys to design, market, and finance IBM solutions on demand.

AZ Licenses Clinomics’ Cell-Signaling Database

Cytomyx Holdings said last week that that its subsidiary Clinomics Biosciences has licensed its Oncology Cell Signaling Database to AstraZeneca.

AstraZeneca has purchased multiple user licenses to the database, which contains protein expression patterns for 100 cell-signaling proteins from more than 30,000 human oncology samples.

Spotfire Sells DecisionSite to Wyeth

Spotfire said last week that Wyeth’s Discovery Research Group has licensed its DecisionSite software.

Wyeth will deploy DecisionSite for Functional Genomics, DecisionSite for Lead Discovery, and DecisionSite Statistics at four discovery sites: Cambridge, Mass.; Collegeville, Pa.; Pearl River, NY; and Princeton, NJ.

Taisho Takes License to Biopendium

Inpharmatica said it has licensed its Biopendium Online genome annotation database to Taisho Pharmaceuticals of Japan.

Taisho is the third Japanese subscriber to Biopendium, and the first to choose the online version, Inpharmatica said.

Geospiza Sells Invoice Software to Hopkins Lab

Geospiza has sold a license for its newly released Finch Customer Invoice Manager to Johns Hopkins University’s Genetic Resources Core Facility.

The application works in conjunction with Geospiza’s Finch Sequencing Center to assist core labs with job invoices, billing, and other financial transactions related to DNA sequencing projects.

Filed under

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more